These miRNAs are involved in the regulation of multiple metabolic pathways, suggesting that urinary EVs may serve as a non-invasive sample source for GDM diagnosis
Understand the realistic timeline for results
doi: 10.1002/oby.24067 63 ArillottaDFlorestaGGuirguisACorkeryJMCatalaniVMartinottiGet al
A liquid pharmaceutical composition consisting of a) semaglutide, optionally b) no more than 0.1 %(w/w) phenol, c) above 6.4 mg/ml sodium chloride, d) buffer, e) at least 60% water, f) histidine, optionally g) one or more agents for adjusting pH, such as HCI, NaOH, or acetate such as sodium acetate or acetic acid, and said composition optionally has a pH of 6-10 such as 7-8
To identify key binding residues, we performed alanine-scanning mutagenesis across BPC157